Dexcom raises outlook after Q3 results top Wall Street estimates

This article was originally published here

Dexcom G6 (NSDQ:DXCM) raised its full-year outlook yesterday after the medical device maker topped expectations on Wall Street with its third-quarter financial results.

The San Diego, Calif.-based company posted profits of $46.6 million, or 53¢ per share, on sales of $266.7 million for the 3 months ended Sept. 30, for sales growth of 44% compared with the same period last year.

Get the full story at our sister site, Drug Delivery Business News.

The post Dexcom raises outlook after Q3 results top Wall Street estimates appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply